Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Priorix-Tetra vs ProQuad co-administered with Havrix and Prevnar in children
NCT00578175Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2007
- Primary completion
- Feb 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of GSK208136 in measles, mumps, rubella and 1 more (3 arms), sponsored by GSK. Primary endpoints: Number of Subjects With Seroresponse for Antibodies to Varicella Virus (VZV) at Day 42, Concentration of Antibodies to Varicella Virus (VZV) at Day 42 and 5 more. Started Nov 2007; status: completed.
02
Drugs
GSK208136
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00578175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578175.